Synthesis and anti-HIV-1 integrase activitiy of cyano pyrimidinones

Archiv der Pharmazie

Volumn 342, Issue 12, 2009, Pages 710-715

  Ramajayam, R ^a   Mahera, Nilesh B ^a   Neamati, Nouri ^b   Yadav, Mange Ram ^a   Giridhar, Rajani ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cyano pyrimidinone; HIV 1 integrase; Phenyl acrylonitrile

Indexed keywords

2 (4 NITROBENZYLTHIO) 4 (3 CHLOROPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (4 NITROBENZYLTHIO) 4 (3 NITROPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (4 NITROBENZYLTHIO) 4 (4 CHLOROPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (4 NITROBENZYLTHIO) 4 (4 METHOXYPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (4 NITROBENZYLTHIO) 6 OXO 4 (4 METHYLPHENYL) 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (4 NITROBENZYLTHIO) 6 OXO 4 PHENYL 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (BENZYLTHIO) 4 (3 NITROPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (BENZYLTHIO) 4 (4 METHOXYPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (BENZYLTHIO) 6 OXO 4 (4 METHYLPHENYL) 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (BENZYLTHIO) 6 OXO 4 PHENYL 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (PHENETHYLTHIO) 4 (3 CHLOROPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (PHENETHYLTHIO) 4 (3 NITROPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (PHENETHYLTHIO) 4 (4 CHLOROPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (PHENETHYLTHIO) 4 (4 METHOXYPHENYL) 6 OXO 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (PHENETHYLTHIO) 6 OXO 4 (4 METHYLPHENYL) 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; 2 (PHENETHYLTHIO) 6 OXO 4 PHENYL 1,6 DIHYDROPYRIMIDINE 5 CARBONITRILE; CYANOPYRIMIDINONE DERIVATIVE; INTEGRASE; INTEGRASE INHIBITOR; PYRIMIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

CELL DEATH; CELL LINE, TUMOR; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HIV INTEGRASE INHIBITORS; HUMANS; MALE; MOLECULAR STRUCTURE; PYRIMIDINONES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 73449129700     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200900066     Document Type: Article

References (33)

1. M. Hogberg, I. Morrison, Expert Opin. Ther. Pat. 2000, 10, 1189-1199; H. Jonckheere, J. Anne, E. De Clercq, Med. Res. Rev. 2000, 20, 129-154.
2. F. Lebon, M. Ledecq, Curr. Med. Chem. 2000, 7, 455-477; J. P. Vacca, J. H. Condra, Drug Discov. Today 1997, 2, 261-272.
3. F. J. Palella, K. M. Delaney, A. C. Moorman, M. O. Loveless, et al., N. Engl. J. Med. 1998, 338, 853-860.
4. J. Cohen, Science 2002, 296, 2320-2324.
5. E. De Clercq, Nat. Rev. Drug Discov. 2002, 1, 13-25.
6. N. Neamati, C. Marchand, Y. Pommier, Adv. Pharmacol. 2000, 49, 147-165.
7. J. d'Angelo, J. F. Mouscadet, D. Desmaele, F. Zouhiri, H. Leh, Pathol. Biol. 2001, 49, 237-246.
8. N. Neamati, Expert Opin. Inv. Drug 2001, 10, 281-296.
9. N. J. Anthony, Curr. Top. Med. Chem. 2004, 4, 979-990.
10. Y. Pommier, A. A. Johnson, C. Marchand, Nat. Rev. Drug Discov. 2005, 4, 236-248.
11. A. Engelman, K. Mizuuchi, R. Craigie, Cell 1991, 67, 1211-1221.
12. P. O. Brown, Integration, Cold Spring Harbor Press, Cold Spring Harbor, NY, USA, 1999.
13. E. Asante-Appiah, A. M. Skalka, Adv. Virus Res. 1999, 52, 351-369.
14. S. Dubey, Y. D. Satyanaraya, H. Lavania, Eur. J. Med. Chem. 2007, 42, 1159-1168.
15. th Conference on "Retroviruses and Opportunistic Infections", Seattle, WA, 2002.
16. A. Billich, Curr. Opin. Invest. Drugs 2003, 4, 206-209.
17. S. Young, Presented at the "XIV International AIDS Conference", West Point, PA, 2002.
18. D. J. Hazuda, S. D. Young, J. P. Guare, N. J. Anthony, et al., Science 2004, 305, 528-532.
19. A. A. Johnson, C. Marchand, Y. Pommier, Curr. Top Med. Chem. 2004, 4, 671-686.
20. M. Witvrouw, B. van Maele, J. Vercammen, A. Hantson, et al., Curr. Drug. Metab. 2004, 5, 291-304.
21. V. Summa, A. Petrocchi, V. G. Matassa, M. Taliani, et al., J. Med. Chem. 2004, 47, 5336-5339; U. Koch, B. Attenni, S. Malancona, S. Colarusso, et al., J. Med. Chem. 2006, 49, 1693-1707.
22. P. Pace, M. E. Di Francesco, C. Gardelli, S. Harper, et al., J. Med. Chem. 2007, 50, 2225-2239.
23. E. Muraglia, O. D. Kinzel, C. Gardelli, B. Crescenzi, et al., J. Med. Chem. 2008, 51, 861-874.
24. M. R. Rico Ferreira, G. Cecere, P. Pace, V. Summa, Tetrahedron Lett. 2009, 50, 148-151.
25. A. Mazumder, A. Gazit, A. Levitzki, M. Nicklaus, et al., Biochemistry 1995, 34, 15111-15122.
26. H. Hongbin Yuan, A. L. Parrill, Bioorg. Med. Chem. 2002, 10, 4169-4183.
27. T. R. Burke Jr., M. R. Fesen, A. Mazumder, J. Wang, et al., J. Med. Chem. 1995, 38, 4171-4178.
28. C. M. Farnet, R. Lipford, B. Wang, F. D. Bushman, Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 9742-9747.
29. C. M. Farnet, B. Wang, M. Hansen, J. R. Lipford, et al., Anti-microb. Agents Chemother. 1998, 42, 2245-2253.
30. V. J. Ram, D. A. Vanden Berghe, A. J. Vlietinck, J. Heterocyclic Chem. 1984, 21, 1307-1312.
31. N. Agarwal, P. Srivastava, S. K. Raghuwanshi, D. N. Upadhyay, et al., Bioorg. Med. Chem. 2002, 10, 869-874.
32. C. Marchand, N. Neamati, Y. Pommier, Methods Enzymol. 2001, 340, 624-633.
33. J. Carmichael, W. G. DeGraff, A. F. Gazdar, J. D. Minna, J. B. Mitchell, Cancer Res. 1987, 47, 936-942.